Pfizer Partners with Enodia on Sec61 Programs

Company Enodia Therapeutics; Pfizer Event Type Research Collaboration and License Agreement Modality Small molecule; Sec61 translocon modulation (protein-synthesis control) Asset Multi-target Sec61 inhibitor discovery program (candidates undisclosed) Target Sec61 (client proteins undisclosed) Disease Area Inflammation; immunology; oncology (undisclosed targets) Summary Enodia Therapeutics and Pfizer entered…